CA2323236A1 - Proteines receptrices humaines; reactifs et procedes associes - Google Patents

Proteines receptrices humaines; reactifs et procedes associes Download PDF

Info

Publication number
CA2323236A1
CA2323236A1 CA002323236A CA2323236A CA2323236A1 CA 2323236 A1 CA2323236 A1 CA 2323236A1 CA 002323236 A CA002323236 A CA 002323236A CA 2323236 A CA2323236 A CA 2323236A CA 2323236 A1 CA2323236 A1 CA 2323236A1
Authority
CA
Canada
Prior art keywords
dirs1
seq
polypeptide
amino acids
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002323236A
Other languages
English (en)
Inventor
Christi L. Parham
Kevin W. Moore
Nicholas J. Murgolo
J. Fernando Bazan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2323236A1 publication Critical patent/CA2323236A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des acides nucléiques codant pour des protéines réceptrices purifiées de mammifères, comme les rongeurs ou les primates, et des fragments de celles-ci. L'invention porte aussi sur des anticorps, polyclonaux et monoclonaux, ainsi que sur des procédés d'utilisation desdites compositions à des fins diagnostiques et thérapeutiques.
CA002323236A 1998-03-09 1999-03-08 Proteines receptrices humaines; reactifs et procedes associes Abandoned CA2323236A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3739498A 1998-03-09 1998-03-09
US09/037,394 1998-03-09
PCT/US1999/003735 WO1999046379A2 (fr) 1998-03-09 1999-03-08 Proteines receptrices humaines; reactifs et procedes associes

Publications (1)

Publication Number Publication Date
CA2323236A1 true CA2323236A1 (fr) 1999-09-16

Family

ID=21894109

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002323236A Abandoned CA2323236A1 (fr) 1998-03-09 1999-03-08 Proteines receptrices humaines; reactifs et procedes associes

Country Status (5)

Country Link
EP (1) EP1062332A2 (fr)
JP (1) JP2002505879A (fr)
AU (1) AU2871899A (fr)
CA (1) CA2323236A1 (fr)
WO (1) WO1999046379A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4741139B2 (ja) * 1999-12-23 2011-08-03 ザイモジェネティクス， インコーポレイテッド 可溶性インターロイキン−２０レセプター
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
WO2001046261A1 (fr) 1999-12-23 2001-06-28 Zymogenetics, Inc. Methode destinee a traiter l'inflammation
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US6927040B2 (en) 2000-06-30 2005-08-09 Zymogenetics, Inc. Interferon-like protein Zcyto21
ES2381650T3 (es) 2000-08-08 2012-05-30 Zymogenetics, Inc. Receptores de citoquinas Zcytor11 solubles
JP4908723B2 (ja) 2000-09-15 2012-04-04 ザイモジェネティクス， インコーポレイテッド 炎症を治療するための方法
US6902930B2 (en) * 2001-08-29 2005-06-07 Vanderbilt University Human Mob-5 (IL-24) receptors and uses thereof
CA2467723C (fr) 2001-12-17 2011-09-27 Zymogenetics, Inc. Methode de traitement du cancer du col de l'uterus
EP1606316A2 (fr) 2003-03-24 2005-12-21 ZymoGenetics, Inc. Anticorps anti-il-20 et leurs partenaires de liaison, methodes d'utilisation de ces derniers dans les cas d'inflammation
EP1927600A1 (fr) 2003-08-07 2008-06-04 Zymogenetics, Inc. Propositions homogènes de IL-28 et IL-29
DE602004023965D1 (de) 2003-11-21 2009-12-17 Zymogenetics Inc Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
JP4898691B2 (ja) 2004-10-22 2012-03-21 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法
BR112012021576A2 (pt) 2010-02-26 2016-10-25 Novo Nordisk As composições estáveis contendo anticorpo.
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169849A1 (fr) * 1993-08-20 1995-03-02 Sidney Pestka Fonction de facteur accessoire pour interferon gamma et son recepteur
CA2177471A1 (fr) * 1993-12-09 1995-06-15 Michel Aguet Chaine .beta. de recepteurs d'ifn-.gamma. et leurs derives

Also Published As

Publication number Publication date
AU2871899A (en) 1999-09-27
EP1062332A2 (fr) 2000-12-27
WO1999046379A3 (fr) 1999-10-21
WO1999046379A2 (fr) 1999-09-16
JP2002505879A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
EP1315743B1 (fr) Genes mammaliens, reactifs et methodes associes
AU2001261351B2 (en) Mammalian receptor proteins; related reagents and methods
US20050009145A1 (en) Mammalian receptor proteins; related reagents and methods
WO1999040195A1 (fr) Proteines de recepteurs de mammiferes; reactifs et procedes apparentes
JP2015007129A (ja) 哺乳動物レセプタータンパク質；関連する試薬および方法
CA2392109A1 (fr) Proteines de recepteurs mammaliens, reactifs et procedes s'y rapportant
CA2323236A1 (fr) Proteines receptrices humaines; reactifs et procedes associes
US7812126B2 (en) DIRS1 polypeptides
US6326472B1 (en) Human receptor proteins; related reagents and methods
US20030082734A1 (en) Mammalian receptor proteins; related reagents and methods
WO1999019480A2 (fr) Proteines receptrices humaines et reactifs et methodes associes
AU2007202362B2 (en) Mammalian receptor proteins; related reagents and methods
MXPA00008848A (en) Human receptor proteins;related reagents and methods

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead